Bringing the fundamentals into focus…
Back to The Pennant Group, Inc.
How The Pennant Group, Inc. stacks up
PNTG · against 453 other Healthcare companies of similar size
Valuation
52/ 100
Below the middle of the pack.
Ranked #232 of 454 · scores higher than 48% of peers
Bars: peers in each 10-point band of the valuation score37 peers with a valuation score of 50–59, including PNTG · Click a bar to see the companies
Why valuation scores 52?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- EBITDA yield is close to the peer norm. EBITDA yield: 4.5% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 2.2% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 63% of peers. Free cash flow yield: 2.4% vs peer median 0.0%
Metric by metric
Position: dot = PNTG, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PNTG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 443 reported | 2.2% | 1.5% | 54% | 30% | |
| EBITDA yieldHigher is better · 457 reported | 3.7% | 4.5% | 46% | 50% | |
| Free cash flow yieldHigher is better · 208 reported | 2.4% | -0.9% | 65% | 20% | |
| Book yieldHigher is better · 447 reported | 24.9% | 40.0% | 30% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around PNTGScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score